Getting a windfall is a double-edged sword if you manage it properly it will help you to enhance your financial status.

Overall volumes in futures & options currently stand at 1.63 crore contracts with a turnover of Rs. 10,11,506.05 crore.

Overall volumes in futures & options currently stand at 1.63 crore contracts with a turnover of Rs. 10,11,506.05 crore.

On the downside, the level 10,680 is likely to act as an immediate resistance as the 100-day moving average is placed at this level. Stocks in news: Shriram Transport Finance, Dr Reddy’s Laboratories, Grasim Industries, BPCL, REC, Jubilant Life Sciences, Tata Steel and Yes Bank.

The outlook for the day flat to negative start as the SGX Nifty at the time of writing is seen trading down by 30 points at 10,737. Also, the cues from the Asian peers are not clear, hence tentativeness may persist, but we cannot rule out bargain hunting at lower levels. Hence, the level of 10,680 would be a crucial support level to watch out for the index. Meanwhile, in a big boost to the public sector banks, the government approved the recapitalisation of Rs 48,239 crore for 12 public sector banks. 

The stocks that are likely to witness significant movement on the bourses on February 21 are Cyient, NHPC, Jindal Worldwide, TRF and Shakti Pumps

Radio City, India’s leading radio network which is a part of Music Broadcast Limited (MBL), has partnered with NMRC (Noida Metro Rail Corporation) to provide passengers with unique entertainment experience during travel. 

HG Infra has been declared as L1 bidder by National Highways Authority of India (NHAI), New Delhi for new EPC project for construction of 6-lane access.

Alembic Pharmaceuticals has announced that it has received approval from US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500 mg.

Strides Pharma Science, Bengaluru-based pharma company announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte. Limited, Singapore has received USFDA approval for Ethosuximide Softgel Capsules.